- Joined
- Dec 17, 2007
- Messages
- 3,486
- Reaction score
- 4,590
1. Patients with primary metastatic nasopharyngeal cancer benefit from RT to the primary disease after response to first line chemotherapy.
2. Oligometastatic prostate cancer patients that benefit the most from RT to the primary may be those with up to 3 bone lesions & no visceral metastasis, independent of nodal disease.
Annals of Oncology | Journal | ScienceDirect.com by Elsevier
Read the latest articles of Annals of Oncology at ScienceDirect.com, Elsevier’s leading platform of peer-reviewed scholarly literature
academic.oup.com
2. Oligometastatic prostate cancer patients that benefit the most from RT to the primary may be those with up to 3 bone lesions & no visceral metastasis, independent of nodal disease.
Annals of Oncology | Journal | ScienceDirect.com by Elsevier
Read the latest articles of Annals of Oncology at ScienceDirect.com, Elsevier’s leading platform of peer-reviewed scholarly literature
academic.oup.com